Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSTIVE pre-operative simvastatin study
NL-OMON34896Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of simvastatin in myocardial ischemia-reperfusion injury (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: C-reactive protein, interleukin-6 and 6 more. Started Jan 2011; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NL-OMON34896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34896.